May 7, 2024

The market’s robust valuation of USD 10.61 billion in 2023 is expected to climb to USD 16.45 billion by 2032, propelled by demographic trends such as the aging global population, and lifestyle shifts leading to a higher incidence of chronic pain conditions like arthritis and back pain. The market is navigating through challenges such as regulatory hurdles […]

Read More